Antidepressant augmentation versus switch in treatment-resistant geriatric depression

Authors

Eric J Lenze, Washington University School of Medicine in St. Louis
Pilar Cristancho, Washington University School of Medicine in St. Louis
Torie R Gettinger, Washington University School of Medicine in St. Louis
Emily Lenard, Washington University School of Medicine in St. Louis
J Philip Miller, Washington University School of Medicine in St. Louis
Ginger E Nicol, Washington University School of Medicine in St. Louis
Vy T Pham, Washington University School of Medicine in St. Louis
Lei Yang, Washington University School of Medicine in St. Louis
et al.

Journal

New England Journal of Medicine

Publication Date

3-23-2023

Volume

388

Issue

12

First Page

1067

Last Page

1079

Document Type

Open Access Publication

DOI

10.1056/NEJMoa2204462

Rights and Permissions

Lenze EJ, Mulsant BH, Roose SP, Lavretsky H, Reynolds CF 3rd, Blumberger DM, Brown PJ, Cristancho P, Flint AJ, Gebara MA, Gettinger TR, Lenard E, Miller JP, Nicol GE, Oughli HA, Pham VT, Rollman BL, Yang L, Karp JF. Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression. N Engl J Med. 2023 Mar 23;388(12):1067-1079. doi: 10.1056/NEJMoa2204462. Copyright © 2023 Massachusetts Medical Society. Reprinted with permission.

Recommended Citation

Lenze, Eric J; Cristancho, Pilar; Gettinger, Torie R; Lenard, Emily; Miller, J Philip; Nicol, Ginger E; Pham, Vy T; Yang, Lei; and et al., "Antidepressant augmentation versus switch in treatment-resistant geriatric depression." New England Journal of Medicine. 388, 12. 1067 - 1079. (2023).
https://digitalcommons.wustl.edu/oa_4/2338

Department

ICTS (Institute of Clinical and Translational Sciences), Psychiatry

Additional Links

Supplemental material is available for this article at publisher site.